Table 2.

Summary of the Number of Censored Events in Ipilimumab Studies

Study Identification No.	No. of Patients	Censored Events
		No.	%
MDX010-20	540	134	24.8
CA184-024	250	51	20.4
CA184-022	217	42	19.4
CA184-008	155	35	22.6
CA184-007	115	43	37.4
CA184-004	82	16	19.5
CA184-042	72	15	20.8
NCI04C0083	88	18	20.4
NCI02C0106	56	7	12.5
NCI03C0109	36	8	22.2
CA184-338	160	76	47.5
CA184-332	90	42	46.7